How Long Does Valium Stay in Your System?

Valium can stay in your system for up to six weeks with regular use. That long window exists because your body breaks diazepam down into a byproduct called nordiazepam, which lingers long after the original dose is gone.

A single dose clears much faster, usually within about a week. But daily use over time changes that picture completely.

So how is Valium different from other benzodiazepines when it comes to detection time?

Key Takeaways

• Valium (diazepam) is detectable in urine for up to 6 weeks with chronic use, due to its long-acting active metabolite, nordiazepam, which has a half-life of up to 100 hours on its own.
• Diazepam’s own elimination half-life ranges from 20 to 100 hours, making it one of the longest-acting benzodiazepines available, according to standard clinical pharmacology references.
• The SAMHSA 2024 National Survey on Drug Use and Health found that approximately 4.8 million people in the United States reported misusing a benzodiazepine in the past year.
• Combining Valium with alcohol or opioids significantly increases the risk of respiratory depression, since all three substances independently suppress central nervous system activity.

Valium Detection Windows by Test Type

Diazepam’s detection window is unusually long compared to shorter-acting benzodiazepines because its active metabolite, nordiazepam, remains pharmacologically active and measurable in the body long after the parent drug itself has cleared.

Urine Testing

Standard urine immunoassays detect diazepam and its metabolites for approximately 6 to 7 days after a single dose, extending to as long as 4 to 6 weeks with chronic, regular use, due to the prolonged half-life of nordiazepam.

Blood Testing

Blood tests detect diazepam for approximately 1 to 6 days after last use, depending on dose and duration of use, and are generally used in clinical or emergency settings rather than routine screening.

Saliva Testing

Saliva testing detects diazepam for roughly 1 to 10 days after last use, offering a shorter window than urine testing but a non-invasive collection method increasingly used in workplace testing.

Hair Testing

Hair follicle testing can detect diazepam use for up to 90 days, since drug metabolites become embedded in the hair shaft as it grows, though it does not reflect very recent use in the days immediately before testing.

Why Valium Stays in the System Longer Than Other Benzodiazepines

Diazepam’s extended detection window is driven by its metabolic pathway rather than the parent drug’s own half-life alone. The liver converts diazepam through CYP2C19 and CYP3A4 enzymes into several active metabolites, most significantly nordiazepam, which itself has a half-life of up to 100 hours. This means the body continues to feel diazepam’s clinical effects, and continues to test positive for it, well after the original dose has technically been metabolized.

Comparison to Shorter-Acting Benzodiazepines

Diazepam’s long half-life places it in clear contrast with shorter-acting benzodiazepines that clear the body within a day or two.

• Alprazolam (Xanax): Has a much shorter half-life of approximately 11 hours, clearing the system faster but producing a more intense, faster-onset withdrawal.
• Chlordiazepoxide (Librium): Also long-acting through its own active metabolites, though generally considered slightly less potent per milligram than diazepam.
• Clonazepam (Klonopin): Shares a similarly long detection window with diazepam; its half-life and detection timeline follow a comparable metabolic pattern.
• Lorazepam (Ativan): Does not produce active metabolites, giving it a more predictable, shorter clearance profile than diazepam.

Factors That Change How Long Valium Stays in Your System

Individual detection times for diazepam vary more widely than for shorter-acting drugs, largely because of how differently people metabolize its active metabolites.

Use Pattern Factors

• Dose and duration of use: A single dose clears far faster than the extended detection window associated with daily use over weeks or months.
• Route of administration: Oral diazepam has a slower onset than intravenous administration, which affects how quickly peak concentration and subsequent clearance occur.
• Co-use with other CNS depressants: Combined use with alcohol or opioids can slow overall clearance and increase the risk of dangerous drug interactions during elimination.

Individual Biological Factors

• Liver function: Since diazepam is metabolized almost entirely by the liver, impaired hepatic function significantly extends its detection window and half-life.
• Age: Older adults metabolize diazepam more slowly, sometimes doubling its effective half-life compared to younger adults.
• Body composition: Diazepam is highly lipophilic, meaning it accumulates in fat tissue and is released back into circulation gradually in people with higher body fat percentage.
• Genetic variation in CYP2C19 activity: Some individuals are genetically slower metabolizers of diazepam’s primary enzymatic pathway, extending clearance time significantly.

Valium Withdrawal Timeline

Diazepam’s long half-life means withdrawal typically has a delayed onset compared to shorter-acting benzodiazepines, but symptoms can also persist longer once they begin.

• 1 to 4 days after last use: Early withdrawal symptoms including anxiety, irritability, and insomnia often begin, delayed by diazepam’s slow clearance.
• 4 to 10 days after last use: Peak withdrawal symptoms typically occur, including tremors, sweating, and in severe cases, seizures.
• 2 to 4 weeks after last use: Physical symptoms generally subside, though this timeline is longer than with shorter-acting benzodiazepines.
• Weeks to months after last use: Protracted withdrawal symptoms, including anxiety and sleep disruption, can persist and are best managed through structured, medically supervised tapering rather than abrupt discontinuation.

Treatment for Valium Use and Withdrawal

Diazepam withdrawal carries a genuine risk of seizures, making medically supervised tapering the safest approach to discontinuation.

Medical Detoxification

Medically supervised detoxification allows diazepam to be tapered gradually under 24-hour nursing supervision, reducing the seizure risk associated with abrupt benzodiazepine discontinuation.

Medication-Assisted Treatment

Medication-assisted treatment protocols may use a longer-acting benzodiazepine taper schedule or adjunct medications to manage withdrawal symptoms safely over several weeks.

Evidence-Based and Adjunct Therapies

• Cognitive Behavioral Therapy (CBT): Addresses the anxiety patterns that often underlie long-term benzodiazepine use.
• Acceptance and Commitment Therapy (ACT): Builds tolerance for anxiety symptoms without relying on benzodiazepines as the primary coping mechanism.
• Somatic therapies: Support nervous system regulation during the extended withdrawal period associated with long-acting benzodiazepines.

Treatment at New Spirit Recovery

New Spirit Recovery treats Valium and other benzodiazepine addiction through a structured, medically supervised taper protocol designed around each person’s dose history and duration of use.

24-Hour Nursing Supervision

Given the seizure risk associated with benzodiazepine withdrawal, New Spirit Recovery provides 24-hour nursing coverage and weekly minimum physician consultations throughout the taper process. The admissions process includes a same-day clinical assessment to determine the appropriate taper schedule before treatment begins.

Dual Diagnosis Care

Because long-term Valium use is frequently connected to an underlying anxiety disorder, New Spirit Recovery’s dual diagnosis program addresses both the physical dependence and the anxiety symptoms that often preceded it.

“Diazepam’s long half-life means people can feel completely fine for several days before withdrawal symptoms start, which catches a lot of families off guard,” says Tabitha Kindet, Nursing Director at New Spirit Recovery. “That delayed onset is exactly why an unsupervised taper at home is so risky.”

Frequently Asked Questions

How long is Valium detectable in urine?

A single dose is typically detectable for 6 to 7 days, while chronic regular use can extend detection up to 4 to 6 weeks due to the long half-life of diazepam’s active metabolite, nordiazepam.

Does Valium show up the same as other benzodiazepines on a drug test?

Standard benzodiazepine immunoassays detect diazepam and its metabolites, but detection windows differ significantly between benzodiazepines depending on each drug’s specific half-life and metabolic pathway.

How long does diazepam withdrawal last?

Peak withdrawal symptoms typically occur 4 to 10 days after last use, with physical symptoms generally subsiding within 2 to 4 weeks, though protracted symptoms can persist longer without structured treatment.

What factors affect how long Valium stays in your system?

Dose, duration of use, liver function, age, body composition, and individual genetic variation in metabolizing enzymes all influence how long diazepam and its metabolites remain detectable.

Is it dangerous to stop taking Valium suddenly?

Yes. Abrupt discontinuation of diazepam after regular use carries a genuine risk of seizures and should always be managed through a medically supervised taper rather than stopped suddenly.

Can Valium use be detected months later?

Hair follicle testing can detect diazepam use for up to 90 days after last use, though it does not indicate use in the days immediately before the test.

References

1. Substance Abuse and Mental Health Services Administration. (2024). 2023 National Survey on Drug Use and Health. U.S. Department of Health and Human Services.
2. Drug Enforcement Administration. (2023). Benzodiazepines drug fact sheet. U.S. Department of Justice.
3. American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.).
4. Griffin, C. E., Kaye, A. M., Bueno, F. R., & Kaye, A. D. (2013). Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner Journal, 13(2), 214-223.
5. ARUP Laboratories. (2023). Drug detection windows and testing methodologies.
6. National Institute on Drug Abuse. (2023). Benzodiazepines and opioids.
7. Ashton, H. (2005). The diagnosis and management of benzodiazepine dependence. Current Opinion in Psychiatry, 18(3), 249-255.